1. Role of early diagnosis and aggressive surgery in the management of invasive pulmonary aspergillosis in neutropenic patients 
D. Caillot, L. Mannone, B. Cuisenier, J.-F. Couaillier 
Clinical Microbiology and Infection 
Volume 7, Pages (January 2001)
DOI: /j tb00010.x
Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions

2. Figure 1
CT halo sign. In the setting of prolonged neutropenia, the ground glass attenuation surrounding the nodule is considered as a typical halo sign and the diagnosis of IPA must highly considered.
Clinical Microbiology and Infection 2001 7, 54-61DOI: ( /j tb00010.x)
Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions

3. Figure 2
CT air-crescent sign. When marrow recovery occurs, an air-crescent sign appeared on the CT scan, owing to detection of aspergillary lesions by PMN. A surgical resection could be indicated if aspergillosis is located near a pulmonary artery due to risk a massive hemoptysis by arterial perforation.
Clinical Microbiology and Infection 2001 7, 54-61DOI: ( /j tb00010.x)
Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions

4. Figure 3
Impact of early diagnosis of IPA on the outcome. Kaplan–Meier survival curves according to the strategy for IPA diagnosis and therapy. Since 1992, progress in early diagnosis (e.g. CT scan, Aspergillus antigenemia detection) combined with a medical-surgical approach were associated with improved survival of IPA patients.
Clinical Microbiology and Infection 2001 7, 54-61DOI: ( /j tb00010.x)
Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions

5. Figure 4
Impact of IPA prognostic factors on the outcome. Kaplan–Meier survival curves according to the presence of three independent factors (fibrinogen level = 9 g/L during the 10 days after IPA diagnosis, absence of CT air-crescent sign during IPA evolution and initial bilateral involvement of the lung by IPA).
Clinical Microbiology and Infection 2001 7, 54-61DOI: ( /j tb00010.x)
Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions